Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on May 1, 2003; DOI 10.1182/blood-2003-03-0708.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-03-0708v1
102/4/1531    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, Z. H.
Right arrow Articles by Ley, T. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, Z. H.
Right arrow Articles by Ley, T. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted March 6, 2003
Accepted April 14, 2003

Long targeting arms do not increase the efficiency of homologous recombination in the {beta}-globin locus of murine embryonic stem cells

Zhi Hong Lu, Jason T Books, Richard M Kaufman, and Timothy J Ley*

Section of Stem Cell Biology, Division of Oncology, Washington University, St. Louis, MO, USA
Harvard Medical School, Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA

* Corresponding author; email: tley{at}im.wustl.edu.

The correction of mutant {beta}-globin genes has long been a therapeutic goal for patients with {beta}-thalassemia or hemoglobinopathies. The use of homologous recombination (HR) to achieve this goal is an attractive approach, since it eliminates the need to include regulatory sequences in the therapeutic construct, and it eliminates mutagenesis induced by random integration. However, HR is a very inefficient process for gene correction, and its efficiency is probably locus dependent. The length of targeting arms is thought to be a determinant of targeting efficiency, so we compared the ability of standard (8 Kb) vs. very long (16, 24, and 110 Kb) regions of homology to correct a mutant murine {beta}-globin gene in embryonic stem cells. Increasing the length of the targeting sequences did not increase the efficiency of HR in this locus, suggesting that alternative approaches will be required to improve the efficiency of this approach for globin gene correction.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
M. Aoyama, K. Agari, G.-H. Sun-Wada, M. Futai, and Y. Wada
Simple and straightforward construction of a mouse gene targeting vector using in vitro transposition reactions
Nucleic Acids Res., March 22, 2005; 33(5): e52 - e52.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020